OBJECTIVES: This study was designed to evaluate bethanechol's efficacy in urinary difficulty, constipation, dry mouth and blurred vision and to evaluate the bethanechol's effect on psychopathology. METHODS: Thirty-two schizophrenic patients who have been treated with antipsychotics and the total score of anticholinergic side effect of 'Rating scale for side effect (no symptom ; 0, severe ; 3)' is above 5 were assigned to three group(controlled group, bethanechol 30 mg/day group, 60 mg/day group). These patients were entered on 6 weeks open trial. Anticholinergic side effects were assessed by 'Rating scale for side effect' and psychopathology by BPRS at base, 2nd week & 4th week. After 4weeks administration of bethanechol, 30 mg/day group was increase to 60 mg/day and 60 mg/day group was decreased to 30 mg/day for 2 weeks for evaluation of dose difference. And then anticholinergic side effects were reassessed at 6th week. RESULTS: There were significant correlations between blurred vision and age. There were no significant improvement of anticholinergic side effect in placebo group but significant improvement of urinary difficulty and dry mouth in 30 mg/day group and significant improvement of urinary difficulty, constipation and dry mouth in 60 mg/day group at 4th week evaluation. In the case dose up(bethanechol 30 mg/day to 60 mg/day) for 2 weeks, dry mouth was more improved. In the case of dose down (60 mg/day to 30 mg/day), the improvements of urinary difficulty and dry mouth were sustained but constipation was aggravated. There were no BPRS changes by bethanechol administration. CONCLUSION: These findings suggest that more than 30 mg/day of bethanechol made improvements in urinary difficulty, constipation, dry mouth, when the total score of Anticholinergic side effect of 'Rating scale for side effect (no symptom ; 0, severe ; 3)' is above 5, although 60 mg/day of bethanechol was more effective than 30 mg/day. Moreover bethanechol administration does not influence psychopathology.
Antipsychotic Agents* ; Bethanechol* ; Constipation ; Humans ; Mouth ; Psychopathology

Background: Postoperative urinary retention is a commonly encountered problem after anal surgery particularly under spinal anesthesia. Bethanchol chloride, a muscarinic cholinergic receptor agonist was used to determine whether it could prevent this problem. Methods: One hundred six patients with mean age of 37+ 9 who underwent anal surgery under spinal anesthesia from January to August 2007 were included in this nonblinded randomized prospective experimental study. Forty- six patients were given bethanechol chloride 25mg/tab 1 hour post- op then another dose after 4-6 hours. Those with the urge to void but unable to do so within the hour or had hypogastric pain (VAS > 8) were immediately catheterized and the amount drain recorded. Conclusion: Although bethanechol chloride did not completely prevent the development of postoperative urinary retention, it use was associated with reduced need for the catheterization.
Human ; Adult ; BETHANECHOL ; URINARY RETENTION ; ANESTHESIA, SPINAL

PURPOSE: In a previous study increasing the extracellular clacium concentration enhanced the phasic contractile response to low frequency stimulation(2Hz) to a significantly greater degree than the enhancement of high frequency stimulation(16Hz). To investigate the sensitivity of the detrusor contractile responses to field stimulation, bethanechol and ATP in calcium free buffer, the current study was designed. MATERIALS AND METHODS: Each rabbit bladder strip of 5x10mm in size was incubated for 30 minutes in the Tyrode's solution. Individual strips were utilized to generate the response to field stimulation(2, 8 and 32Hz), bethanechol(1.0-250microM) or ATP(0.25-2mM). Upon completion of the first stimulation in Tyrode's solution, each tissue was washed 3 1.tomes at 15 minute intervals with fresh Tyrodes. At 15 minutes following the last wash, the Tyrode's solution was replaced with solution containing no calcium+1.0mM EGTA and incubated for ditional 5, 15 or 30 minutes. At the end of 5, 15 or 30-min period of tulibration a second round of field stimulation or dose-response curves to bethanechol or ATP were generated. The contractile responses were monitored via an FT03 force transducer and recorded on a Grass 7D polygraph and expressed as the g tension per 100mg of tissue. RESULTS: (1) Progressive decrease in both basal tension and spontaneous contractile activity (2) more rapid decrease in the contractile response to 2 and 8Hz field stimulation than to 32Hz stimulation (3) more rapid decrease in the contractile response to lower concentrations of bethanechol and ATP than to high concentrations (4) greater maximal inhibition of the contractile response to low concentrations of bethanechol and ATP than to high concentrations. CONCLUSIONS: These results indicated that detrusor contractility to a sub-maximal stimulation rather than maximal stimulation is more sensitive to extracellular calcium depletion.
Adenosine Triphosphate* ; Bethanechol* ; Calcium* ; Egtazic Acid ; Poaceae ; Transducers ; Urinary Bladder*

VUR is usually diagnosed by standard voiding cystourethrography(VCU). However, we are sometimes puzzled not being able to find VUR on VCU in the group of patients in whom VUR is highly suspected from accompanying obvious clinical, urographic and endoscopic features. For the purpose of detecting this type of VUR or 'subclinical VUR, VCU was performed after subcutaneous injection of bethanechol chloride in 3 patients who were highly suspected of VUR and two were diagnosed as subclinical VUR . Case 1 was diagnosed left VUR(grade II ) and case 2 was diagnosed right VUR(grade II) on VCU after' subcutaneous injection of bethanechol chloride. Both underwent unilateral ureteroneocystostomy and are on follow-up. Bethanechol chloride induced voiding cystourethrography is suggested to be a highly method to detect subclinical vesicoureteral reflux.
Bethanechol* ; Follow-Up Studies ; Humans ; Injections, Subcutaneous ; Vesico-Ureteral Reflux*

PURPOSE: This study was designed to investigate the direct effects of ethanol and its metabolites, acetaldehyde and acetic acid, on isolated rat bladder muscle. MATERIALS AND METHODS: For measuring of isometric tension change, rat bladder muscle strips were used. Following ethanol(0.25-3%) was applied to bethanechol(0.1mM)-precontracted muscle strips, acetaldehyde(0.1 to 10mM) and acetic acid(0.1 to 10mM) were applied to resting muscle strips respectively, and were applied to bethanechol(0.1 mM)-precontracted muscle strips respectively. RESULTS: Bladder contraction of tissue strips induced by bethanechol was reduced by ethanol in a dose-dependent manner. Acetaldehyde(1 to 10mM) and acetic acid(5 to 1 0mM) increased the rssting tension(control group), and acetaldehyde(0.1 to 10mM) and acetic acid(0.1 to 10mM) applied to bethanechol-induced contraction enhanced significantly contraction compared to control group. CONCLUSIONS: The results of this study indicate that responses of the rat bladder muscle were reduced by exposure to ethanol, and however, acetaldehyde and acetic acid affect the resting tension itself and show synergistic effect to bethanechol in bladder contractility. These suggest that all of the acute ethanol intoxication did not cause to urinary retention in human with benign prostatic hyperplasia.
Acetaldehyde ; Acetic Acid ; Animals ; Bethanechol ; Ethanol* ; Humans ; Prostatic Hyperplasia ; Rats* ; Urinary Bladder* ; Urinary Retention

Bethanechol promotes bladder emptying by acting on postganglionic parasympathetic effector cells within detrusor muscle to elicit a contraction and is widely used to enhance bladder emptying for incomplete lower motor neuron lesion, idiopathic hypotonic bladder end postoperative urinary retention. However its effects on bladder outlet is inconclusive. Therefore, in vitro study for the effects of bethanechol on the muscle strip from the rabbit bladder neck were undertaken. Ten male white rabbit bladders were divided into body, base and neck and contractile responses of three strips were done. Bethanechol chloride produces most potent contractile response on the bladder body and comparatively less on the bladder base and bladder neck in a dose-dependant manner. Maximal contractile pressures of bladder body and bladder neck were 6.29+/-0.72 and l.22+/-0.53gm tension respectively. Norepinephrine produce maximal contractile responses of 2.09+/-0.49gm tension on bladder body. 1.15+/-0.39 on bladder base and 2.6+/-0.55 on bladder neck. Contractile response or the bladder neck to bethanechol was 50% of those to norepinephrine. These results indicated that bethanechol produce contractile response on the rabbit bladder neck in some degree but weaker than those by norepinephrine.
Bethanechol* ; Humans ; Male ; Motor Neurons ; Neck* ; Norepinephrine ; Urinary Bladder* ; Urinary Retention

Pharmacologic treatment of the detrusor hypocontractility(hyporeflexia) remains controversial issues. Clean intermittent self catheterization(CIC) alone, or combination with bethanechol chloride has been generally accepted as treatment modality. Until presently, bethanechol chloride is the only pharmacologic agent commonly used for bladder emptying without significant complication. However, the effectiveness of bethanechol seem to be episodic. The present study compared the contractile response of various pharmacologic agents including bethanechol chloride, ATP, PG E1, E2, F2-alpha on the smooth muscle strips of male rabbit bladder. In addition, effect of the gastrointestinal motility agents such as cisapride and metoclopramide on the contraction of rabbit bladder were assessed. Each bladder was divided into bladder body and bladder base for comparison of pharmacologic effects. FS at basal tension elicited a frequency dependent contraction which was greater in bladder body strips than in bladder base strips. The contractile responses to bethanechol, ATP, PG E1, E2 and PG F2-alpha were greater in bladder body than in bladder base.In the bladder body,magnitude of the contractile responses by ATP and PG F2-alpha were approximately 1/3 of those by bethanechol or FS.PG F2-alpha was consistently more potent to produce contraction than PG E1, E2. ATP induced contraction only consisted of initial phasic rise of tension. The contraction induced by PG developed slower than those caused by bethanechol. Cisapride(10uM) induced weak contractile responses comparable to those by PG E1 Metoclopramide had no contractile effects in this studies. Conclusively, differences exist in the response of the bladder body and base to FS and various pharmacologic agents. ATP, PG E2 and PG F2-alpha exhibited some notable contractile responses to the bladder body that were approximately 1/3 of those by bethanechol. Gastrointestinal motility agents were not shown to be effective in the mediation of contraction of rabbit bladder.
Adenosine Triphosphate ; Bethanechol ; Cisapride ; Gastrointestinal Motility ; Humans ; Male ; Metoclopramide ; Muscle, Smooth* ; Negotiating ; Urinary Bladder*

BACKGROUND: Urinary retention is one of the most common complications after spinal anesthesia, and its inadequate management can result in serious outcomes. Overdistended bladder due to urinary retention should be catheterized. This study determined whether the prophylactic medication of oral bethanechol, a parasympathomimetic drug, results in reduction in the frequency of catheterization due to urinary retention. METHODS: Twenty-seven healthy male patients undergoing lower extremity operation under spinal anesthesia were subjected and randomly allocated into three groups according to the drug which was given. Group I (n = 9) had no medication, Group II (n = 9) and Group III (n = 9) were given bethanechol 50 mg or bethanechol 100 mg orally, respectively, before anesthesia. We measured the number of catheterized patients, the frequency of catheterization per catheterized patient, and perioperative cardiovascular complications in each group after their operations. RESULTS: The number of catheterized patients was nine (100%) in Group I, three (33%) in Group II, and two (22%) in Group III (P < 0.002). There was a significant statistical difference among the groups (P < 0.002). As the dosage of bethanechol increased, its effect increased relatively (P < 0.001). CONCLUSIONS: Prophylactic oral medication of 50 100 mg bethanechol reduces the frequency of catheterization in urinary retention after spinal anesthesia.
Anesthesia ; Anesthesia, Spinal* ; Bethanechol* ; Catheterization ; Catheters ; Humans ; Lower Extremity ; Male ; Premedication* ; Urinary Bladder* ; Urinary Retention

BACKGROUND: Urinary retention is one of the most common complications after spinal anesthesia, and its inadequate management can result in serious outcomes. Overdistended bladder due to urinary retention should be catheterized. This study determined whether the prophylactic medication of oral bethanechol, a parasympathomimetic drug, results in reduction in the frequency of catheterization due to urinary retention. METHODS: Twenty-seven healthy male patients undergoing lower extremity operation under spinal anesthesia were subjected and randomly allocated into three groups according to the drug which was given. Group I (n = 9) had no medication, Group II (n = 9) and Group III (n = 9) were given bethanechol 50 mg or bethanechol 100 mg orally, respectively, before anesthesia. We measured the number of catheterized patients, the frequency of catheterization per catheterized patient, and perioperative cardiovascular complications in each group after their operations. RESULTS: The number of catheterized patients was nine (100%) in Group I, three (33%) in Group II, and two (22%) in Group III (P < 0.002). There was a significant statistical difference among the groups (P < 0.002). As the dosage of bethanechol increased, its effect increased relatively (P < 0.001). CONCLUSIONS: Prophylactic oral medication of 50 100 mg bethanechol reduces the frequency of catheterization in urinary retention after spinal anesthesia.
Anesthesia ; Anesthesia, Spinal* ; Bethanechol* ; Catheterization ; Catheters ; Humans ; Lower Extremity ; Male ; Premedication* ; Urinary Bladder* ; Urinary Retention

Contraction of the bladder can be divided into two phases. The initial phase (phasic contraction) is characterized by a rapid increase in pressure that results in a change of bladder shape. This phase is followed immediately by a plateau phase (tonic contraction) that maintains an increase in intravesical pressure that is responsible for evacuating the bladder. This study was designed to determine the effect of relief of bladder outlet obstruction on the phasic and tonic detrusor contractile response to field and pharmacologic stimulation in rat urinary bladder. Forty female rats were used in this investigation. Normal bladder was used as control(n=8) and experimental groups (n=32) were classified into 6 weeks obstruction group and 2, 4, and 6 weeks groups after relief of obstruction. The phasic and tonic contractile response to field stimulation (2, 4, 8, 16, 32 Hz) and bethanechol (3 x -100,000 M) was estimated by polygraph. Following results were obtained. 1) The weight of bladder was increased in obstruction group and gradually decreased after relief of obstruction (p<0.05). 2) The phasic and tonic contractile response to all frequency of stimulation was decreased in obstruction group and rapidly recovered from 4 weeks after relief of obstruction (p<0.05). 3) In low frequency field stimulation, the ratio of tonic to phasic contractile response was decreased in obstruction group when compared with control (p<0.05) and in all frequency field stimulation, the ratio tended to recover after relief of obstruction (p>0.05). 4) Detrusor contractile response to bethanechol was rapidly decreased in obstruction group and rapidly recovered after relief of obstruction. And the contractile response in 6 weeks after relief of obstruction was higher than control (p<0.05). As the results of above, we concluded that relief of bladder outlet obstruction induced recovery of the ability to initiate contraction2 However, emptying ability is not recovered within a certain period of time. And further study will be needed.
Animals ; Bethanechol ; Female ; Humans ; Rats* ; Urinary Bladder Neck Obstruction* ; Urinary Bladder*